Research of the system of information providing for safe pharmacotherapy pregnancy in the world

  • N. M. Maksymovych Danylo Halytsky Lviv National Medical University
  • I. G. Mudrak National Pirogov Memorial Medical University Vinnytsya
  • O. M. Zaliska Danylo Halytsky Lviv National Medical University
Keywords: drug safety, pregnancy, information support for pregnant women, databases

Abstract

Improvement of information provision for safe and rational use of medicines at pregnancy is a priority task for all system of healthcare in the world. The purpose of this study was to analyze and carry out a systematic analysis of information sources, databases, registries operating on the international, state, professional levels on the safe use of medicines, including duration pregnancy in the countries of the world. Summarized recommendations, directives of the World Health Organization about safety of pharmacotherapy, especially during pregnancy, and the need for improvement information provision for the appointment of drugs during pregnancy, since 50% and more pregnant women use more than 4 drugs.

Systematized the main sources of information, a database of safe use of medicines during prеgnancy in Europe and the United States on professional levels, as well as specially for patients. The directions of the real word data collection were shown and made the establishment of registries of pregnant women taking medications that allow monitoring of adverse reactions during pregnancy. The modern trends on improving information provision by Food and Drug Administration (FDA) also for instructions and labeling of drugs depending on the risk category of pregnancy were presented. The use of modern information sources, databases, patient registries is relevant to provision of rational use of medicines, especially for pregnant women in Ukraine.

References

1. WHO Patient Safety [Electronic resource]. – Access to the resource: http://www.who.int/patientsafety/about/en/

2. Shlyakhy vykorinennya medychnykh pomylok, abo bezpeka patsiyentiv yak kontrapunkt okhorony zdorov'ya [Elektronnyy resurs]. – Rezhym dostupu: http://www.apteka.ua/article/402281

3. Mitchell A. A., Gilboa S. M., Werler M. M. et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008 // Am. J. Obstet. Gynecol. – 2011. – V. 205, N 1. – P. 51.

4. CDC Medications and Pregnancy [Electronic resource]. – Access to the resource: https://www.cdc.gov/pregnancy/meds/treatingfortwo/facts.html

5. Kersten I., Haas J. P., Fusch C. et al. Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study // BMC Pregnancy Childbirth. – 2014 [Electronic resource]. – Access mode: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC3943445/

6. Pinto I. C., Machado A. P. The Impact of Chronic Diseases during Pregnancy on the Fetus and Mother Health: A Literature Review // Women's Health Science J. [Electronic resource]. – Access mode: https://medwinpublishers.com/ WHSJ/WHSJ16000101.pdf

7. Patient Safety Global Action Summit [Electronic resource]. – Access to the resource: http://www.who.int/patientsafety/ministerial_summit_16/en/

8. Second Global Ministerial Summit on Patient Safety (2017) [Electronic resource]. – Access to the resource: http://www.who.int/patientsafety/policies/ ministerial_summit_17/en/

9. Medication Without Harm: WHO’s Third Global Patient Safety Challenge [Electronic resource]. – Access to the resource: http://www.who.int/patientsafety/ medication-safety/en/

10. European medicines agency [Electronic resource]. – Access to the resource: http://www.hma.eu/ermsfg.html

11. Public Health England [Electronic resource]. – Access to the resource: https://www.gov.uk/government/organisations/public-health-england

12. Health care in Germany: The German health care system [Electronic resource]. – Access to the resource: https://www.ncbi.nlm.nih.gov/pubmedhealth/ PMH0078019/

13. EUPATI [Electronic resource]. – Access to the resource: https://www.eupati.eu/ reliable-information/

14. Ципкун А. Г. Репродуктивна безпечність та фетальний ризик лікарських засобів // Репродуктивная эндокринология. – № 5 (19). – С. 15–21.

15. World Health Organization [Electronic resource]. – Access to the resource: http://www.who.int/patientsafety/implementation/checklists/childbirth/en/

16. WHO safe childbirth checklist implementation guide: improving the quality of facility-based delivery for mothers and newborns [Electronic resource]. – Access to the resource: http://apps.who.int/iris/bitstream/10665/199177/1/ 9789241549455_eng.pdf

17. WHO recommendations on maternal health [Electronic resource]. – Access to the resource: http://www.who.int/maternal_child_adolescent/documents/maternal-health-recommendations/en/

18. European Board and College of Obstetrics and Gynaecology [Electronic resource]. – Access to the resource: https://www.ebcog.org/

19. The American College of Obstetricians and Gynecologists [Electronic resource]. – Access to the resource: https://www.acog.org/

20. European Surveillance of Congenital Anomalies [Electronic resource]. – Access to the resource: http://www.eurocat-network.eu/

21. European Network of Teratology Information Services [Electronic resource]. – Access to the resource: https://www.entis-org.eu/

22. The Organization of Teratology Information Specialists [Electronic resource]. – Access to the resource: www.mothertobaby.org

23. Teratogen Information System [Electronic resource]. – Access to the resource: http://depts.washington.edu/terisdb/

24. Reproductive Toxicology Center [Electronic resource]. – Access to the resource: https://reprotox.org/

25. List of Pregnancy Exposure Registries [Electronic resource]. – Access to the resource: https://www.fda.gov/ScienceResearch/SpecialTopics/Womens HealthResearch/ucm134848.htm

26. National Pregnancy Registry for Antidepressants [Electronic resource]. – Access to the resource: https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/

27. Food and Drug Administration Тhe Рregnancy and Lactation Labeling Rule (PLLR) [Electronic resource]. – Access to the resource: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm

28. Perni S., DeMaagd G. The New Pregnancy and Lactation Labeling Rule // P T. – 2016. – V. 41, N 11. – Р. 713–715.

29. Pro zatverdzhennya devʺyatoho vypusku Derzhavnoho formulyara likarsʹkykh zasobiv ta zabezpechennya yoho dostupnosti. Nakaz MOZ Ukrayiny vid 03. 04. 2017 № 363. [Elektronnyy resurs]. – Rezhym dostupu: http://www.dec.gov. ua/index.php/ua/informatsijno-poshukova-sistema-elektronnij-formulyar

30. Ukrayins'ka teratolohichna informatsiyna systema [Elektronnyy resurs]. – Rezhym dostupu: http://utis.in.ua/
Published
2018-08-14
How to Cite
Maksymovych, N. M., Mudrak, I. G., & Zaliska, O. M. (2018). Research of the system of information providing for safe pharmacotherapy pregnancy in the world. Farmatsevtychnyi Zhurnal, (1-2), 22-31. https://doi.org/10.32352/0367-3057.1-2.18.03
Section
Management of pharmacy

Most read articles by the same author(s)